Home>Clinical Outcomes>New Coeliac Disease Assessment Questionnaire (CDAQ) available from Isis Outcomes
New Coeliac Disease Assessment Questionnaire (CDAQ) available from Isis Outcomes
13th August 2015
Evaluating health-related quality of life (HRQOL) in people with coeliac disease with Coeliac Disease Assessment Questionnaire (CDAQ).
A new 32-item patient reported outcome measure has been developed by researchers within the Health Services Research unit, part of the Nuffield Department of Population Health at the University of Oxford, to investigate the health-related quality of life of people living with coeliac disease.
The CDAQ was designed according to current best-practice guidelines. The measure can be used in a range of settings, including clinical trials and clinical practice. Further assessment of the CDAQ’s reliability and validity is currently underway.
The CDAQ and other Oxford Health Outcomes questionnaires are available from Isis Outcomes.
Isis Outcomes is an activity within Technology Transfer at Oxford University Innovation Ltd, dedicated to the provision and support of the highest quality PROs for healthcare providers and the medical product industry.
Industry enquiries to:
Dr David Churchman
Technology Transfer Manager, Oxford University Innovation
E david.churchman@innovation.ox.ac.uk
T +44 (0)1865 614417
Media enquiries to:
Renate Krelle
Media & Business Communications Manager, Oxford University Innovation Ltd
E: renate.krelle@innovation.ox.ac.uk
T: +44 (0)1865 280867